Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

Published:2020-06 Issue: Volume:86 Page:102017
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Garcia Josep,Hurwitz Herbert I.,Sandler Alan B.,Miles David,Coleman Robert L,Deurloo Regula,Chinot Olivier L

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference131 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer;Ferrara;Nat Rev Drug Discov,2004

3. The biology of VEGF and its receptors;Ferrara;Nat Med,2003

4. The Complexity of Translating Anti-angiogenesis Therapy from Basic Science to the Clinic;Ye;Dev Cell,2016

5. Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?;Li;Cancer Biol Med,2016

Cited by 684 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer;Anti-Cancer Agents in Medicinal Chemistry;2024-11

3. Antitumor effects of IOX1 combined with bevacizumab-induced apoptosis and immunity on colorectal cancer cells;International Immunopharmacology;2024-11

4. Recent Approaches on Molecular Markers, Treatment and Novel Drug Delivery System Used for the Management of Colorectal Cancer: A Comprehensive Review;Current Pharmaceutical Biotechnology;2024-11

5. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3